Phaos Technology Holdings (Cayman) (POAS) Liabilities and Shareholders Equity (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) posted Liabilities and Shareholders Equity of $1.3 million for Q4 2025, down 11.65% on a QoQ basis from $1.4 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Liabilities and Shareholders Equity history runs 2 years deep, the most recent figure standing at $1.3 million for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | 13.32 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | 37.13 Bn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 6.63 Bn |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | 10.46 Bn |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | 31.92 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.19 Mn | 6.13 Mn | - | 1.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 1.28 Mn |
| Apr 30, 2025 | 1.45 Mn |
| Apr 30, 2024 | 3.85 Mn |